Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fored

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Arthritis and Rheumatism|June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenJohan Askling, C Michael Fored, Lena Brandt, et al.
Arthritis and Rheumatism|October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Annals of the Rheumatic Diseases|January 31, 2007
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsJohan Askling, C Michael Fored, Lena Brandt, et al.
Annals of the Rheumatic Diseases|September 29, 2011
Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth patternAurélie Ambrosi, Stina Salomonsson, Håkan Eliasson, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Arthritis and Rheumatism|June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenJohan Askling, C Michael Fored, Lena Brandt, et al.
Arthritis and Rheumatism|October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Annals of the Rheumatic Diseases|January 31, 2007
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsJohan Askling, C Michael Fored, Lena Brandt, et al.
Annals of the Rheumatic Diseases|September 29, 2011
Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth patternAurélie Ambrosi, Stina Salomonsson, Håkan Eliasson, et al.
Pageof 4